Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Rilzabrutinib and Bruton tyrosine kinase inhibition for the treatment of persistent or chronic immune thrombocytopenia.
Journal: Expert opinion on pharmacotherapy
Published: October 13, 2025
Rilzabrutinib.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: October 08, 2025
New Developments in the Treatment of IgG4-Related Disease: A Comprehensive Clinical Approach.
Journal: Journal of clinical medicine
Published: August 31, 2025
Evaluating rilzabrutinib in the treatment of immune thrombocytopenia.
Journal: Immunotherapy
Published: August 11, 2025
From C481 Resistance Evasion to Platelet Preservation: Rilzabrutinib Redefines ITP Targeted Therapy.
From C481 Resistance Evasion to Platelet Preservation: Rilzabrutinib Redefines ITP Targeted Therapy.
Journal: Drug design, development and therapy
Published: May 29, 2025
BTK modulates systemic immune activation to bacterial translocation in primary antibody deficiencies.
Journal: The Journal of allergy and clinical immunology
Published: March 17, 2025
Rilzabrutinib for the Treatment of Immune Thrombocytopenia.
Journal: European journal of haematology
Published: February 26, 2025
Highlights from the 66th ASH Annual Meeting 2024.
Journal: Acta haematologica
Published: January 27, 2025
Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence.
Journal: Mediators of inflammation
Published: January 03, 2025
Last Updated: 10/31/2025